Abstract
Actinium-225 (225Ac) has attracted global attention due to its applications in cancer therapy. A new 225Ac production method is proposed by muon nuclear-capture reactions with negative muons (μ−) irradiating on a 226Ra target. The 225Fr is produced by 226Ra (μ−, n ν) 225Fr reaction and decays to 225Ra. The 225Ra subsequently decays to 225Ac. The method produces no carrier-added 225Ac, and 213Bi from a 225Ac-213Bi generator. The production method by muon nuclear-capture reactions with the 226Ra target is described. The radioactivity of 225Ac and 213Bi are calculated assuming the reaction branching ratio of 226Ra (μ−, n ν) 225Fr.
Similar content being viewed by others
References
World Nuclear Association, Radioisotopes in medicine, https://www.world-nuclear.org/information-library/non-power-nuclear applications/radioisotopes-research/radioisotopes-in-medicine.aspx
Kim YS, Brechbiel MW (2012) An overview of targeted alpha therapy. Tumor Biol 33:573–590
Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, Mottaghy F, Kopka K, Apostolidis C, Haberkorn U, Morgenstern A (2016) 225Ac-PSMA-617 for PSMA-targeted a-radiation therapy of metastatic castration-resistant prostate cancer. J Nucl Med 57:1941–1944
Robertson AKH, Ramogida CF, Schaffer P, Radchenko V (2018) Development of 225Ac radiopharmaceuticals: TRIUMF perspectives and experiences. Curr Radiopharm 11:156–172
Morgenstern A, Apostolidis C, Kratochwi C, Sathekge M, Krolicki L, Bruchertseifer F (2018) An overview of targeted alpha therapy with 225Actinium and 213Bismuth. Curr Radiopharm 11:200–208
Qaim SM (2020) Medical radionuclei production. In: Gruyter D (Ed.), Science and technology
Radchenko V, Morgenstern A, Jalilian AR, Ramogida CF, Cutler C, Duchemin C, Hoehr C, Haddad F, Bruchertseifer F, Gausemel H, Yang H, Osso JA, Washiyama K, Czerwinski K, Leufgen K, Pruszyński M, Valzdorf O, Causey P, Schaffer P, Perron R, Maxim S, Wilbur DS, Stora T, Li Y (2021) Production and supply of α-particle-emitting radionuclides for targeted α-therapy. J Nucl Med 62:1495–1503
Firestone RB (1996) Table of isotopes. CD-ROM Eighth Edition, Version 1.0
Mirzadeh S (1998) Generator -produced alpha-emitters. Appl Radiat Isot 49:345–349
Apostolidis C, Molinet R, Rasmussen G, Morgenstern A (2005) Production of Ac-225 from Th-229 for targeted α therapy. Anal Chem 77:6288–6291
Hogle S, Boll RA, Murphy K, Denton D, Owens A, Havelock TJ, Garland M, Mirzadeh S (2016) Reactor production of Thorium-229. Appl Radiat Isot 114:19–27
Maslov OD, Sabel’nikov AV, Dmitriev SN (2006) Preparation of 225Ac by 226Ra (γ, n) photonuclear reaction on an electron accelerator MT-25 microtron. Radiochemistry 48:195–197
Melville G, Meriarty H, Metcalfe P, Knittel T, Allen BJ (2007) Production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226. Appl Radiat Isot 65:1014–1022
Melville G, Allen BJ (2009) Cyclotron and linac production of Ac-225. Appl Radiat Isot 67:549–555
Apostolidis C, Molinet R, McGinley J, Abbas K, Möllenbeck A, Morgenstern A (2005) Cyclotron production of Ac-225 for targeted alpha therapy. Appl Radiat Isot 62:383–387
Engle JW, Ignatyuk AV, Capote R, Carlson BV, Hermanne A, Kellett MA, Kibédi T, Kim G, Kondev FG, Hussain M, Lebeda O, Luca A, Nagai Y, Naik H, Nichols AL, Nortier FM, Suryanarayana SV, Takács S, Tárkányi FT, Vercelli M (2019) Recommended nuclear data for the production of selected therapeutic radionuclides. Nucl Data Sheet 155:56–74
Zhuikov BL, Kalmykov SN, Ermolaev SV, Aliev RA, Kokhanyuk VM, Matushko VL, Tananaev IG, Myasoedov BF (2011) Production of 225Ac and 223Ra by irradiation of Th with accelerated protons. Radiochemistry 53:73–80
Ermolaev SV, Zhuikov BL, Kokhanyuk VM, Matushko VL, Kalmykov SN, Aliev RA, Tananaev IG, Myasoedov BF (2012) Production of actinium, thorium and radium isotopes from natural thorium irradiated with protons up to 141 MeV. Radiochim Acta 100:223–229
Weidner JW, Mashnik SG, John KD, Hemez FM, Ballard B, Bach H, Birnbaum ER, Bitteker LJ, Couture A, Dry D, Fassbender ME, Gulley MS, Jackman KR, Ullmann JL, Wolfsberg LE, Nortier FM (2012) Proton-induced cross sections relevant to production of 225Ac and 223Ra in natural thorium targets below 200 MeV. Appl Radiat Isot 70:2602–2607
Weidner JW, Mashnik SG, John KD, Ballard B, Birnbaum ER, Bitteker LJ, Couture A, Fassbender ME, Goff GS, Gritzo R, Hemez FM, Runde W, Ullmann JL, Wolfsberg LE, Nortier FM (2012) 225Ac and 223Ra production via 800 MeV proton irradiation of natural thorium targets. Appl Radiat Isot 70:2590–2595
Mastren T, Radchenko V, Owens A, Copping R, Boll R, Griswold R, Mirzadeh S, Wyant LE, Brugh M, Engle JW, Nortier FM, Birnbaum ER, John KD, Fassbender JME (2017) Simultaneous separation of actinium and radium isotopes from a proton irradiated thorium matrix. Scient Rep 7:8216
Matsuzaki T (2014) Radioactive materials generated by muon irradiation, and production method thereof. Patent JP2014196997A
Matsuzaki T, Ishida K, Nagamine K, Watanabe I, Eaton GH, Williams WG (2001) The RIKEN-RAL pulsed muon facility. Nucl Instr Meth A 465:365–383
The Paul Scherrer Institute, The PSI proton accelerator. https://www.psi.ch/media/the-psi-proton-accelerator
TRIUMF, Main cyclotron & beam lines. https://www.triumf.ca/research-program/research-facilities/main-cyclotron-beam-lines
Rutherford Appleton Laboratory, ISIS neutron and muon source. https://stfc.ukri.org/research/our-science-facilities/isis-neutron-and-muon-source/
J-PARC, Materials and life science experimental facility. https://j-parc.jp/c/en/facilities/mlf/index.html
Niikura M, Saito TY, Matsuzaki T, Ishida K, Hiller A (2024) Measurement of the production branching ratios following nuclear muon capture for palladium isotopes using the in-beam activation method. Phys Rev C 109:014328
Measday DF (2001) The nuclear physics of muon capture. Phys Rep 354:243–409
Measday DF, Stocki TJ, Tam H (2007) γ rays from muon capture in I, Au, and Bi. Phys Rev C 75:045501
Backenstoss G, Charalambus S, Daniel H, Hamilton WD, Lynen U, Von Der Malsburg C, Poelz G, Povel HP (1971) Nuclear γ rays following muon capture. Nucl Phys A. https://doi.org/10.1016/0375-9474(71)90253-3
Budick B, Anigstein R, Kast JW (1982) Nuclear excitation in the 207Pb (μ-, ν6n) 201Tl. Phys Lett 110B:375–378
Singer P (1962) Neutron emission following muon capture in heavy nuclei. Nuovo Cim 23:669–689
Fricke G, Bernhardt C, Heilig K, Schaller LA, Schellenberg L, Shera EB, De Jager CW (1995) Nuclear ground state charge radii from electromagnetic interactions. At Data Nucl Data Tables 60:177–285
McDevitt MR, Finn RD, Sgouros G, Ma D, Scheinberg DA (1999) An 225Ac/213Bigenerator system for therapeutic clinical applications: construction and operation. Appl Radiat Isot 50:895–904
Morgenstern A, Bruchertseifer F, Apostolidis C (2012) Bismuth-213 and actinium-225 generator performance and evolving applications of two generator-derived alpha-emitting radioisotopes. Curr Radiopharm 5:221–227
2022 Actinium-225 User Group Meeting - DOE isotope program. https://www.youtube.com/watch?v=eR1k0AkPrlI
Actinium-225 (Thorium-229 decay product) Product information. https://isotopes.gov/sites/default/files/2023-07/Ac-225%20Thorium%20Decay.pdf
μE1 beam line, Paul Sherrer Institute (PSI). https://www.psi.ch/en/smus/e1
Fermi Research Alliance, FRA (2014) Mu2e technical design report. Fermilab-TM-2594
Miscetti S et al. (2020) Status of the Mu2e experiment at Fermilab. Fermilasb-conference-20–389-V
The COMET Collaboration (2020) COMET Phase-I technical report. Program theory expermental physics, 033C01: 102
Reduction and resource recycling of high-level radioactive wastes through. Nuclear transmutation. https://www.jst.go.jp/impact/en/program/08.html
Acknowledgements
A part of the research was funded by the ImPACT Program of the Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan) [43].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Matsuzaki, T., Sakurai, H. 225Ac production via 226Ra (μ−, n ν) 225Fr reaction with 226Ra target. J Radioanal Nucl Chem (2024). https://doi.org/10.1007/s10967-024-09514-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10967-024-09514-6